Teng Wei Chen
Director/Board Member bij AIMFINITY INVESTMENT CORP. I
Profiel
Teng Wei Chen is an Independent Director at Aimfinity Investment Corp.
I and Inkstone Feibo Acquisition Corp.
He is also a Director at New-Shine Biomedical Co., Ltd.
Dr. Chen holds a doctorate degree from China Medical University (Taiwan).
Actieve functies van Teng Wei Chen
| Bedrijven | Functie | Begin |
|---|---|---|
| AIMFINITY INVESTMENT CORP. I | Director/Board Member | 17-03-2023 |
Inkstone Feibo Acquisition Corp.
 Inkstone Feibo Acquisition Corp. Financial ConglomeratesFinance Inkstone Feibo Acquisition Corp. is a blank check company, which engages in effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It focuses on opportunities in biotechnology and green technology industries with an emphasize on environmental, social, and governance (ESG) practices in the United States and Taiwan. The company was founded on April 20, 2022 and is headquartered in Wilmington, DE. | Director/Board Member | - |
| New-Shine Biomedical Co., Ltd. | Director/Board Member | 01-01-2018 |
Opleiding van Teng Wei Chen
| China Medical University (Taiwan) | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| AIMFINITY INVESTMENT CORP. I | Finance |
| Bedrijven in privébezit | 2 |
|---|---|
Inkstone Feibo Acquisition Corp.
Inkstone Feibo Acquisition Corp. Financial ConglomeratesFinance Inkstone Feibo Acquisition Corp. is a blank check company, which engages in effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It focuses on opportunities in biotechnology and green technology industries with an emphasize on environmental, social, and governance (ESG) practices in the United States and Taiwan. The company was founded on April 20, 2022 and is headquartered in Wilmington, DE. | Finance |
| New-Shine Biomedical Co., Ltd. |
